Lactic acidosis pathophysiology

Jump to navigation Jump to search

Lactic acidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lactic acidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lactic acidosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lactic acidosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lactic acidosis pathophysiology

CDC on Lactic acidosis pathophysiology

Lactic acidosis pathophysiology in the news

Blogs on Lactic acidosis pathophysiology

Directions to Hospitals Treating Lactic acidosis

Risk calculators and risk factors for Lactic acidosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Lactic acidosis occurs when cells make lactic acid faster than it can be metabolized. [1] [2] Both overproduction of lactate, or reduced metabolism, lead to acidosis. Normal lactate levels are less than 2 mmol/L, lactate levels between 2 mmol/L and 4 mmol/L are defined as hyperlactatemia. Severe hyperlactatemia is a level of 4 mmol/L or higher. Other definitions for lactic acidosis include: pH less than or equal to 7.35 and lactatemia greater than 2 mmol/L with a partial pressure of carbon dioxide (PaC02) less than or equal to 42 mmHg.

Pathophysiology

After glycolysis, pyruvate is shunted into two main pathways.

  • Anaerobic conditions result in pyruvate channeling into the Cori cycle (lactic acid cycle), where pyruvate is converted to lactate, to regenerate NAD+ from NADH. The NAD+ generated can now be utilized in glycolysis again, forming two molecules of ATP per molecule of glucose. The lactate produced gets sent to the liver, for gluconeogenesis[3].

Acid generation on the cellular level is dictated by the ratio of NAD+ and NADH. These molecules help maintain the intracellular pH by influencing the ratio of pyruvate to lactate. Therefore, an increased NADH concentration results in an increased lactate level. Causes of increased NADH include a hypoxic state, ingestion and oxidation of large amounts of ethanol.

In the lactic acidosis associated with shock, a marked increase in lactate production driven by catecholamine stimulation of glycolysis is a key mechanism. A similar process is likely responsible for the lactic acidosis that occurs when high doses of inhaled beta agonists are used to treat severe asthma.[4] There are types of lactic acidosis based on the process that leads to an increased lactate level. Type A is is due to hypovolemia leading to hypoxia, type B involves an offending drug (metformin has been associated[5]) or toxin.[6]

Normally, there is a very high metabolic potential for lactate utilization, as demonstrated in patients with grand mal seizures[7] which is not utilized in acidosis states. This difference may be due to decreased lactate clearance in hypovolemic disorders such as shock, where lactic acidosis occurs despite a mild increase in lactate formation[8].

Lactic acidosis is an underlying process in the development of rigor mortis. Tissue in the muscles of the deceased resort to anaerobic metabolism and significant amounts of lactic acid are released into the muscle tissue. This along with the loss of ATP causes the muscles to grow stiff.

References

  1. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016
  2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:68 ISBN 140510368X
  3. Katz J, Tayek JA (1999). "Recycling of glucose and determination of the Cori Cycle and gluconeogenesis". Am J Physiol. 277 (3): E401–7. doi:10.1152/ajpendo.1999.277.3.E401. PMID 10484349.
  4. Meert KL, McCaulley L, Sarnaik AP (2012). "Mechanism of lactic acidosis in children with acute severe asthma". Pediatr Crit Care Med. 13 (1): 28–31. doi:10.1097/PCC.0b013e3182196aa2. PMID 21460758.
  5. Alivanis P, Giannikouris I, Paliuras C, Arvanitis A, Volanaki M, Zervos A (2006). "Metformin-associated lactic acidosis treated with continuous renal replacement therapy". Clin Ther. 28 (3): 396–400. doi:10.1016/j.clinthera.2006.03.004. PMID 16750454.
  6. Fall PJ, Szerlip HM (2005). "Lactic acidosis: from sour milk to septic shock". J Intensive Care Med. 20 (5): 255–71. doi:10.1177/0885066605278644. PMID 16145217.
  7. Orringer CE, Eustace JC, Wunsch CD, Gardner LB (1977). "Natural history of lactic acidosis after grand-mal seizures. A model for the study of an anion-gap acidosis not associated with hyperkalemia". N Engl J Med. 297 (15): 796–9. doi:10.1056/NEJM197710132971502. PMID 19702.
  8. Lindinger MI, Heigenhauser GJ, McKelvie RS, Jones NL (1992). "Blood ion regulation during repeated maximal exercise and recovery in humans". Am J Physiol. 262 (1 Pt 2): R126–36. doi:10.1152/ajpregu.1992.262.1.R126. PMID 1733331.


Template:WikiDoc Sources